EUVIMEDEUVIMED entdecken
Crossref

Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS

Wenhong Jiang, Rundong Guo, Shuyao Wang, Xiangqi Li, Zenan Zhang, Qijun Sun, Jiayong Piao, Zheng Zhao, Shulong Yang, Zhaozhu Li

The FASEB Journal · 2026

DOI: 10.1096/fj.202504385rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Wenhong Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Fibrosis, Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Key Research and development program of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis (RF) is a pivotal pathological feature in the progression of chronic kidney disease (CKD), yet its underlying mechanisms remain incompletely elucidated. Urine‐derived stem cells (USCs) exhibit significant potential in tissue repair due to their robust paracrine function. This study aimed to investigate whether miRNAs derived from USC‐derived exosomes (USC‐Exos) can inhibit RF and to elucidate the underlying molecular mechanisms. Based on preliminary research, miR‐26a‐5p was identified as a key regulatory molecule through miRNA high‐throughput sequencing of USC‐Exos. Integrative transcriptomic and single‐cell sequencing analyses revealed the expression characteristics and functional networks of its potential target gene, Nras , during the RF process. Subsequently, dual‐luciferase reporter gene assays confirmed that miR‐26a‐5p directly targets NRAS and negatively regulates its expression, thereby inhibiting fibroblast proliferation, migration, and the expression of fibrotic markers α‐SMA and Collagen I. Further mechanistic studies demonstrated that miR‐26a‐5p also suppresses the activation of the MAPK signaling pathway and mechanical signaling molecules (including PTK2 , SRC , RHOA , and ROCK1 ), reduces nuclear translocation of YAP protein, and inhibits F‐actin polymerization. Animal experiments confirmed that exosome‐delivered miR‐26a‐5p significantly attenuates renal histopathological damage, reduces collagen deposition, and downregulates the expression of various fibrosis‐related molecules. This study elucidates that miR‐26a‐5p from USC‐Exos alleviates RF progression by targeting NRAS, inhibiting the MAPK signaling pathway, and suppressing mechanical microenvironment activation, providing a potential novel strategy for clinical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExosomesFibrosisStem CellsMembrane ProteinsGTP PhosphohydrolasesKidneyAnimalsMiceHumansMaleCell ProliferationCell MovementMonomeric GTP-Binding Proteins

Stichwörter der Autor:innen

NRASchronic kidney diseasemiR‐26a‐5prenal fibrosisurine‐derived stem cells

Substanzen

MicroRNAsMembrane ProteinsGTP PhosphohydrolasesNras protein, mouseMirn26 microRNA, mouseNRAS protein, humanMIRN26 microRNA, humanMonomeric GTP-Binding Proteins

Autor:innen und Institutionen

  • The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China.

Förderung

  • Key Research and development program of Heilongjiang Province

Zitieren

APA

Jiang, W., Guo, R., Wang, S., Li, X., Zhang, Z., Sun, Q., Piao, J., Zhao, Z., Yang, S., & Li, Z. (2026). Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS. The FASEB Journal. https://doi.org/10.1096/fj.202504385rr

Vancouver

Jiang W, Guo R, Wang S, Li X, Zhang Z, Sun Q, et al. Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS. The FASEB Journal. 2026. doi:10.1096/fj.202504385rr

BibTeX
@article{Jiang2026,
  author = {Jiang, Wenhong and Guo, Rundong and Wang, Shuyao and Li, Xiangqi and Zhang, Zenan and Sun, Qijun and Piao, Jiayong and Zhao, Zheng and Yang, Shulong and Li, Zhaozhu},
  title = {Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202504385rr}
}
Kostenlos starten →